Libenzapril | m-entrepreneurship.com

Product Name :
Libenzapril

Search keywords :
Libenzapril

drugId :
null

Target Vo:
Angiotensin-converting enzyme

Target Vo Short Name :
ACE

Moa_Name:
Angiotensin-converting enzyme inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hypertension

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Pan Cytokeratin Antibody
JNK1+JNK2+JNK3 Antibody
Cleaved PARP Antibody: Cleaved PARP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 89 kDa, targeting to Cleaved PARP. It can be used for WB,ICC,IP,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts